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LETTER TO THE EDITOR
Usefulness of a specialized
« tattoo » consultation in a
tertiary care hospital: a one-year
experience
Editor
Seventeen per cent of the French have tattoos.1 The frequency of
tattoo complications ranges broadly from 2% to 27%.2–4 The
management of these complications may leave the physician
puzzled. Besides, physicians could feel uncomfortable at properly
advising patients with chronic conditions who wish to have a
tattoo.5 We report the 1-year experience of a monthly consulta-
tion in Bichat-Claude Bernard University Hospital in Paris.6 The
consultation admits patients with tattoo complications and also,
on a case-by-case basis, patients with medical conditions before
tattooing. We do not provide laser removal services.
We prospectively collected the data of all the outpatients who
attended the consultation between May 2017 and June 2018
(12 months). Sixty-four consultations were carried out (median:
6/month) for 52 outpatients (27 men, 52%). The median age
was 33 years (16–80 years). Tattoo types were permanent tat-
toos (94%, n = 49), permanent make-up (4%, n = 2) and henna
(2%, n = 1). Tattoos had been performed outside tattoo shops
(“home tattooing”) in 7 cases (16%) and during a tattoo con-
vention in one (2%). Five patients had their tattoo abroad. Two
patients had immunomodulatory treatments during tattooing
(methotrexate and adalimumab for spondylarthritis; interferon
beta for multiple sclerosis). Sixty-six per cent (n = 34) presented
Table 1 Reasons for referral and diagnosis for 52 outpatients
n (%)
Outpatients attending for a past or present tattoo complicationsa 44 (85)
Allergy to an ink colorb 15 (33)
Warm color (red, orange, yellow) 12 (73)
Cold color (blue, violet) 3 (27)
Infection 8 (18)
Pyogenic infection (S. aureus) 1 (2)
Environmental nontuberculous mycobacteriac 3 (7)
Viral warts 1 (2)
Possible pyogenic infectiond 3 (7)
Foreign body granuloma/sarcoidosis 4 (9)
Sarcoidosis 1 (2)
Isolated pruritus on a part or whole tattoo 4 (9)
Scars on tattoos; repetitive delay in healing after tattooing 4 (9)
Dyschromia 4 (9)
Hyperpigmentation (after henna tattoo) 1 (2)
Color fading (permanent make-up) 1 (2)
Poor cosmetic permanent make-up result 1 (2)
Post-inflammatory hyperpigmentation after
attempt of tattoo removal
1 (2)
Tumors 2 (4.5)
Solitary keratoacanthoma 1 (2)
Eruptive keratoacanthomae 1 (2)
Miscellaneous 4 (9)
Lipoma in the vicinity of the tattoo 1 (2)
Tattoo blowout 1 (2)
Localized pain 1 (2)
Melanocytic naevus covered by a tattoo 1 (2)
Unspecified 6 (14)
Outpatients attending before a first tattoo 8 (15)
Scar camouflage 3 (37.5)
Acne/folliculitis 2 (25)
Chronic urticaria, dermographism 1 (12.5)
Past allergy to nickel, chrome and cobalt 1 (12.5)
Fear of tattoo complications 1 (12.5)
aOne patient may present here several diagnosis.
bAmong those patietns, one had a generalized lichenoid reaction/lichen pla-
nus and two patients had sunlight triggered reaction on orange/yellow color.
cTwo patients had been tattooed in the same tattoo parlour.
dTattoos were normal or with scars upon examination. Diagnosis was consid-
ered as possible upon the story of the patient and if available patients own
tattoo pictures.
eThe patient presented also an lichenoid tattoo reaction to the red color of
the tattoo along with eruptive nodules.
Figure 1 Spectrum of tattoo complications. (a) Eczematous and
lichenoid sunlight-triggered tattoo allergy to orange, (b) mycobac-
terial infection on the grey shades of a tattoo performed in Cape
Verde, (c) ulcerated keratoacanthoma and lichenoid red tattoo
reaction, (d) infection by S aureus after tattooing, (e) nodules on a
red tattoo during sarcoidosis, (f) lympho-histiocytic tattoo reaction
to red and orange, (g) lichenoid tattoo reaction to violet.
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with active symptoms on one tattoo or more, and 19% (n = 10)
had an asymptomatic tattoo with or without visible sequelae
(scarring or dyschromia) (Fig. 1). The reasons for consultation
and diagnoses are summarized in Table 1. Briefly, main diag-
noses included tattoo allergy (33%) and infection (18%).
Ultrapotent corticosteroid ointments or topical tacrolimus was
applied for tattoo allergies and granulomas, while long-term
antibiotics were indicated for mycobacteria infection. Keratoa-
canthomas were removed surgically, including the complete
excision of the whole tattoo in a case. The remaining 15% of
outpatients (n = 8) sought for advice before a first tattoo.
Patients were satisfied with this specialized consultation for
either diagnosis and treatment or advice. This consultation is
unique in France.6 To our knowledge, there are currently three
other ‘clinics’ of this kind in Copenhagen,7 Amsterdam8 and
New York. The ‘tattoo clinic’ in Copenhagen reported its experi-
ence of 405 patients between 2008 and 2015.7 The number of
patients (50/year) and distribution of complications (allergic
reactions, 37%; bacterial infections 11%) were similar.7 Sixteen
per cent of our patients reported complications on ‘home-made’
tattoos, even though they were allegedly done by ‘professional’
tattooists. This figure was similar in Denmark (14%).7 They did
not present only infection, but also variously scarring, delay in
healing, colour allergy, keratoacanthoma or itch. A better infor-
mation of the public about the increased risks of home tattooing
is warranted.
The median number of monthly consultations was rather
‘low’ in comparison with the number of tattooed individu-
als. We estimated that 176 000 tattooed individuals could
present symptoms in France, as 1.9% of the respondents in
our study reported chronic symptoms on at least one tat-
too.1 Our consultation is subjected to selection bias as
patients with most disabling symptoms are looking for
advices and usually live at a reasonable distance from Paris.
During the same 12 months, one of us (NK) also collected
38 tattoo complications from France through e-mail notifica-
tions, either via physicians, tattoo artists or tattooed individ-
uals. Studies based on self-reports may excessively detect
minor symptoms and complaints that have little impact and
do not need any management.3
In conclusion, a specialized ‘tattoo’ consultation displayed a
variety of tattoo complications. It has its place in a university
hospital setting. A monthly pace seems currently sufficient
despite tattooing popularity. We hope that additional consulta-
tions will open in other parts of France and Europe to better
address this issue and research purposes as well.
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